A de novo frameshift FGFR1 mutation extending the protein in an individual with multiple epiphyseal dysplasia and hypogonadotropic hypogonadism without anosmia.

Eur J Med Genet 2019 Oct 9:103784. Epub 2019 Oct 9.

Division of Medical Genetics, Department of Pediatrics, CHU Sainte-Justine Hospital, University of Montreal, Montreal, Canada. Electronic address:

Multiple epiphyseal dysplasia (MED) is a genetically and clinically heterogeneous disease with both dominant and recessive inheritance. Eight different genes are known to cause the disease but in 15% of cases of MED, no mutation is found. Fibroblast growth factor receptor 1 (FGFR1) is a crucial regulator of bone formation and when mutated, can cause diseases with skeletal manifestations; nevertheless, MED has not been described in individuals with FGFR1 mutations. In this report, we describe a proband with MED and congenital normosmic hypogonadotropic hypogonadism (HH). DNA analysis showed a de novo frameshift variant in FGFR1 likely explaining the HH (p.Arg852Thrfs*165). No other mutation was found after a large gene sequencing panel, exome sequencing and an array CGH, except for a variant of unknown significance in FBN1 (rs755375255), but there were no features of a disease associated with FBN1 mutations and this variant is found a few times in population databases. We thus discuss the possibility that MED might be a new skeletal feature associated with FGFR1 mutations.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejmg.2019.103784DOI Listing
October 2019
3 Reads
1.486 Impact Factor

Publication Analysis

Top Keywords

fgfr1 mutations
8
hypogonadotropic hypogonadism
8
multiple epiphyseal
8
novo frameshift
8
epiphyseal dysplasia
8
med
5
fgfr1
5
skeletal manifestations
4
diseases skeletal
4
mutated diseases
4
mutations report
4
manifestations med
4
individuals fgfr1
4
med described
4
fbn1 rs755375255
4
described individuals
4
formation mutated
4
fbn1 mutations
4
fgfr1 crucial
4
panel exome
4

Similar Publications